OSE Immunotherapeutics SA (OSE.PA)

EUR 5.9

(-1.01%)

Operating Expenses Summary of OSE Immunotherapeutics SA

  • OSE Immunotherapeutics SA's latest annual operating expenses in 2023 was 23.58 Million EUR , down -19.78% from previous year.
  • OSE Immunotherapeutics SA's latest quarterly operating expenses in 2024 Q2 was 21.25 Million EUR , down 0.0% from previous quarter.
  • OSE Immunotherapeutics SA reported a annual operating expenses of 38.78 Million EUR in annual operating expenses 2022, down -15.09% from previous year.
  • OSE Immunotherapeutics SA reported a annual operating expenses of 45.67 Million EUR in annual operating expenses 2021, up 32.68% from previous year.
  • OSE Immunotherapeutics SA reported a quarterly operating expenses of 18.73 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • OSE Immunotherapeutics SA reported a quarterly operating expenses of 11.23 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of OSE Immunotherapeutics SA (2023 - 2012)

Historical Annual Operating Expenses of OSE Immunotherapeutics SA (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 23.58 Million EUR -19.78%
2022 38.78 Million EUR -15.09%
2021 45.67 Million EUR 32.68%
2020 34.42 Million EUR 12.75%
2019 30.53 Million EUR 55.79%
2018 19.59 Million EUR 1.08%
2017 19.38 Million EUR 12.88%
2016 17.17 Million EUR 207.21%
2015 5.59 Million EUR 97.07%
2014 2.83 Million EUR 1034.8%
2013 250 Thousand EUR -82.7%
2012 1.44 Million EUR 0.0%

Peer Operating Expenses Comparison of OSE Immunotherapeutics SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -464.736%
ABIVAX Société Anonyme 127.37 Million EUR 81.481%
Adocia SA 15.62 Million EUR -50.931%
Aelis Farma SA 18.81 Million EUR -25.347%
Biophytis S.A. 14.33 Million EUR -64.578%
Advicenne S.A. 8.21 Million EUR -187.145%
genOway Société anonyme 16.73 Million EUR -40.928%
IntegraGen SA 5.35 Million EUR -340.709%
Medesis Pharma S.A. 1.56 Million EUR -1407.697%
Neovacs S.A. 10.34 Million EUR -128.055%
NFL Biosciences SA 4.37 Million EUR -439.257%
Plant Advanced Technologies SA 2.76 Million EUR -753.175%
Quantum Genomics Société Anonyme 1.71 Million EUR -1273.078%
Sensorion SA 27.05 Million EUR 12.807%
Theranexus Société Anonyme 3 Million EUR -684.995%
TME Pharma N.V. 5.49 Million EUR -329.125%
Valbiotis SA 9.86 Million EUR -139.021%
TheraVet SA 1.64 Million EUR -1334.581%
Valerio Therapeutics Société anonyme 20.32 Million EUR -16.088%
DBV Technologies S.A. 89.4 Million EUR 73.616%
Genfit S.A. 54.8 Million EUR 56.958%
GeNeuro SA 14.35 Million EUR -64.3%
Innate Pharma S.A. 64.57 Million EUR 63.468%
Inventiva S.A. 120.18 Million EUR 80.373%
MaaT Pharma SA 21.59 Million EUR -9.218%
MedinCell S.A. 32.92 Million EUR 28.349%
Nanobiotix S.A. 58.92 Million EUR 59.969%
Poxel S.A. 28.76 Million EUR 17.994%
GenSight Biologics S.A. 32.66 Million EUR 27.774%
Transgene SA 31.23 Million EUR 24.469%
Valneva SE 134.92 Million EUR 82.517%